DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Onapristone is an investigational drug.
There have been 9 clinical trials for Onapristone. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2021.
The most common disease conditions in clinical trials are Breast Neoplasms, Endometrial Neoplasms, and Ovarian Neoplasms. The leading clinical trial sponsors are Context Therapeutics, Arno Therapeutics, and Memorial Sloan Kettering Cancer Center.
Recent Clinical Trials for Onapristone
|A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer||Context Therapeutics||Phase 1|
|A Study of Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer||Memorial Sloan Kettering Cancer Center||Phase 1|
|Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)||University of Wisconsin, Madison||Phase 2|